HIGHFDA DRUG

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 16, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
March 16, 2026
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CINACALCET, Cipla USA Inc.
Model numbers
Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026, Lot 5PB0173, exp January-2027
UPC codes
69097-410, 69097-411, 69097-412, 69097-410-02, 69097-411-02, 69097-412-02
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 16, 2026

  2. Reported by FDA DRUG

    April 22, 2026

  3. RecallRadar source check

    April 29, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for CINACALCET recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02. Generic: CINACALCET; Brand: CINACALCET. Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit. Classification: Class II. Quantity: 113,336 bottles. Distribution: Nationwide in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot
expiry: Lot 4PB0526
4PB0527
4PB0528
exp September-2026
+2 more
UPC Codes
69097-410
69097-411
69097-412
+3 more
Affected States
ALL
Report Date
April 22, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls